Skip to content
DraconiticResearch
Search Sources API
210,423 studies31 sourcesUpdated 52 min ago

Oncology

5,311 studies490 in 7 days2,547 in 30 days

Filters
Type
Date
Clear

Latest

5,311 studies

  1. Successful conservative management of hepatic portal venous gas complicating severe immune-related gastrointestinal injury during pembrolizumab-based concurrent chemoradiotherapy for cervical cancer: a mechanistic case report
    Miwa Minamitani, Hideaki Tsuyoshi, Tatsushi Naito +2
    Frontiers in oncologyPeer-reviewedCC BYFull textOncologyEurope PMCCrossref
  2. IL27RA ubiquitination by CBL E3 ligase regulates IL27 dependent immune response against EBV- induced infectious mononucleosis
    Jing Su, Jinbin Fan, Jijin Qi +7
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  3. Effects of extensive passaging on the characteristics of pancreatic ductal adenocarcinoma cancer cell line HG008-T
    Zhiyong He, Jerilyn R. Izac, Alexander A. Gooden +4
    Scientific ReportsPeer-reviewedCC BY 4.0Full text1 citedOncologyCrossref
  4. Comparative analysis of Illumina and Ultima-Genomics sequencing for plasma cell-free small RNA profiling in pancreatic cancer
    Amit Levon, Hadas Volkov, Rani Shlayem +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  5. The effect of time to nephrectomy on cancer‐specific mortality in pathological T stage (pT)1b–2 renal cancer
    Michele Nicolazzini, Federico Polverino, Leonardo Quarta +15
    Bju InternationalPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  6. Development and preliminary clinical characterization of an MDT-defined surgical-window framework for complex pancreatic cancer: a retrospective cohort study.
    Xingfei Li, Delin Ma, Tantu Ma +4
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  7. Analysis of prognostic features associated with extracellular matrix and lymph node metastasis in colorectal cancer.
    Xuefang Chen, Feng Qiu, Rujie Peng +4
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  8. The role of the p53 signaling pathway in prostate cancer.
    Rui Shi, Hongbing Fu, Xinye Wang +5
    Translational andrology and urologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  9. Radiotherapy and immune checkpoint inhibitors in small cell lung cancer: a Web of Science Core Collection-based bibliometric analysis.
    Weihan Wang, Zhonghua Chen, Yang Wang +2
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  10. Real-world outcomes of neoadjuvant targeted therapy in resectable epidermal growth factor receptor mutation-positive non-small cell lung cancer: a retrospective study.
    Jia Li, Yinguang Zhang, Jie Gao +5
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  11. Perioperative treatment for resectable non-small cell lung cancer harboring EGFR exon 20 insertion mutations: a narrative review from advanced-stage evidence to whole-course precision management.
    Zhuoran Li, Yichao Han, Wenzhao Zhong +1
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  12. Segmental distribution of hepatic steatosis on opportunistic low-dose computed tomography: a Couinaud-based analysis.
    Ingrid Galvis, Jonathan Alis, Mary Salvatore
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  13. Surgical de-escalation strategies for non-small cell lung cancer following neoadjuvant chemoimmunotherapy: a propensity score-matched analysis.
    Yulong Wang, Bengang Hui, Xin Wang +3
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  14. An immunogenic cell death-related classification for prognostic stratification and immunotherapy response prediction in proficient mismatch repair/microsatellite stable colorectal cancer.
    Jia He, Jinxiu Qu, Yuan Zhao +5
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  15. Pre-transplant locoregional therapy and post-transplant outcomes in hepatocellular carcinoma: a single-center retrospective cohort study.
    Eyad Gadour, Elsayed Abdulaziz Gadalla, Iftikhar Khan +10
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  16. MYL9 silencing inhibits proliferation and migration of lung adenocarcinoma cells: a potential therapeutic target.
    Xiang Tan, Yejun Chen, Minlian Nong +2
    Journal of thoracic diseasePeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  17. Pathological high-risk feature count and survival outcomes in patients with stage I invasive lung adenocarcinoma (≤3 cm): a retrospective cohort study.
    Jie Cao, Nan Chen, Yin Ku +9
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  18. Prognostic value of a three-dimensional spatial classification system for clinical T1a-bN0 non-small cell lung cancer in the superior segment.
    Yihan Yang, Angat Naresh Chadha, Yingchao Gu +6
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  19. Perioperative and early oncologic outcomes of complex segmentectomy via uniportal video-assisted thoracic surgery for primary lung cancer.
    Takuya Watanabe, Eriko Suzuki, Naoko Yoshii +4
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  20. Explainable machine learning for predicting grade ≥3 treatment-related adverse events in resectable non-small cell lung cancer receiving neoadjuvant chemoimmunotherapy: predominant contribution of hematologic toxicity.
    Fei-Hang Zhi, Yunzeng Zhang, Tengfei Ge +14
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  21. Adjuvant immunotherapy after curative-intent treatment for hepatocellular carcinoma: evidence, limitations, and a research framework for molecular residual disease-guided intervention-a narrative review.
    Bin Bai, Xian Su, Feilong Zhou +2
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  22. An improved scoring method for human epidermal growth factor receptor-2 immunohistochemical staining in breast cancer.
    Rui Guo, Yi Tian, Qiaoling Yu +3
    Translational cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  23. Development and internal validation of a multimodal deep learning model integrating imaging, clinical and pathological features to predict false-negatives in non-specific benign lung biopsies: a dual-center study.
    Jing Yuan, Wei Li, Chunhua Liu +6
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  24. Diagnostic challenge of delayed immune-related hepatitis during zongertinib treatment after nivolumab plus ipilimumab in a 52-year-old man with HER2-mutant non-small cell lung cancer: a case report.
    Tomohiro Oba, Shunya Shiohira, Yoko Machida +4
    Translational lung cancer researchPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC
  25. Neoadjuvant transarterial chemoembolization, camrelizumab, and apatinib for centrally located hepatocellular carcinoma (NEO-CENTACT): study protocol for a phase II trial.
    Yang Zou, Junjun Tao, Zhijun Kuang +3
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMCPMC